Downregulation of SNAIL sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by regulating the NF-κB pathway

Wan,Zhaojun; Pan,Huazheng; Liu,Shihai; Zhu,Jingjuan; Qi,Weiwei; Fu,Kai; Zhao,Teng; Liang,Jun

doi:10.3892/or.2015.3743

Downregulation of SNAIL sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by regulating the NF-κB pathway

Authors:
- Zhaojun Wan
- Huazheng Pan
- Shihai Liu
- Jingjuan Zhu
- Weiwei Qi
- Kai Fu
- Teng Zhao
- Jun Liang
View Affiliations

Affiliations: Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, P.R. China, Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, P.R. China, Department of Central Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, P.R. China
Published online on: January 20, 2015 https://doi.org/10.3892/or.2015.3743
Pages: 1560-1566

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hepatocellular carcinoma (HCC) is the sixth most common cancer and the second most lethal cancer worldwide. Evidence has shown HCC cell resistance to TRAIL‑mediated apoptosis. In a previous study, we verified that silencing SNAIL downregulated the growth of HCC cells. In addition, the mechanism of resistance to TRAIL in HCC cells was connected with the activation of nuclear factor-κB (NF-κB). Thus, it was hypothesized that the downregultaion of SNAIL sensitizes HCC cells to TRAIL-induced apoptosis by regulating the NF-κB pathway. In the present study, the most effective lentiviral vectors carrying shRNA against SNAIL were selected and adenoviral vectors harboring TRAIL were constructed. The expression of SNAIL and TRAIL was detected by quantitative PCR and western blotting. HCC cell viability and apoptosis were assessed using an MTT assay and the Hoechst test. To determine how to sensitize HCC cells to TRAIL-induced apoptosis after silencing SNAIL, p53 was assessed by western blot analysis. We also investigated the expression of Bcl-xL, cIAP2, survivin and Raf-1 protein using western blot analysis and the apoptotic degree of HuH-7 cells was detected using the Hoechst test following the suppression of each gene, which was a possible molecular mechanism to sensitive TRAIL-induced apoptosis through the downregulation of SNAIL in HCC cells. Silencing SNAIL resulted in increased apoptosis by enhancing sensitization to TRAIL in all the HCC cells. Additionally, p53 protein was upregulated in HuH-7 cells. Expression of Bcl-xL, cIAP2, survivin and Raf-1 was downregulated following silencing of SNAIL, while downregulation of any of the proteins contributed to SNAIL suppression enhancing HCC cell sensitivity to TRAIL‑induced apoptosis, with the exception of cIAP2. The results demonstrated that silencing SNAIL can sensitize TRAIL-induced apoptosis in HCC cells by upregulating p53 protein and by regulating related genes of the NF-κB pathway such as Bcl-xL, survivin and Raf-1.

View Figures

View References

1	Marquardt JU and Thorgeirsson SS: SnapShot: hepatocellular carcinoma. Cancer Cell. 25:5502014. View Article : Google Scholar : PubMed/NCBI
2	Yang JD and Roberts LR: Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol. 7:448–458. 2010. View Article : Google Scholar : PubMed/NCBI
3	Yamanaka Y, Shiraki K, Inoue T, Miyashita K, Fuke H, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K and Nakano T: COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis. Int J Mol Med. 18:41–47. 2006.PubMed/NCBI
4	Chun E and Lee KY: Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells. Biochem Biophys Res Commun. 315:771–779. 2004. View Article : Google Scholar : PubMed/NCBI
5	Ogunwobi OO and Liu C: Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways. Clin Exp Metastasis. 28:721–731. 2011. View Article : Google Scholar : PubMed/NCBI
6	Yang Y, Zhu J, Gou H, Cao D, Jiang M and Hou M: Clinical significance of Cox-2, Survivin and Bcl-2 expression in hepatocellular carcinoma (HCC). Med Oncol. 28:796–803. 2011. View Article : Google Scholar
7	Deng Q, Zhang Z, Feng X, et al: TRAIL-secreting mesenchymal stem cells promote apoptosis in heat-shock-treated liver cancer cells and inhibit tumor growth in nude mice. Gene Ther. 21:317–327. 2014. View Article : Google Scholar : PubMed/NCBI
8	Ashkenazi A and Dixit VM: Apoptosis control by death and decoy receptors. Curr Opin Cell Biol. 11:255–260. 1999. View Article : Google Scholar : PubMed/NCBI
9	Benedict CA and Ware CF: TRAIL: not just for tumors anymore? J Exp Med. 209:1903–1906. 2012. View Article : Google Scholar : PubMed/NCBI
10	Garimella SV, Gehlhaus K, Dine JL, Pitt JJ, Grandin M, Chakka S, Nau MM, Caplen NJ and Lipkowitz S: Identification of novel molecular regulators of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in breast cancer cells by RNAi screening. Breast Cancer Res. 16:R412014. View Article : Google Scholar : PubMed/NCBI
11	Yamanaka T, Shiraki K, Sugimoto K, Ito T, Fujikawa K, Ito M, Takase K, Moriyama M, Nakano T and Suzuki A: Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines. Hepatology. 32:482–490. 2000. View Article : Google Scholar : PubMed/NCBI
12	Ganten TM, Koschny R, Haas TL, Sykora J, Li-Weber M, Herzer K and Walczak H: Proteasome inhibition sensitizes hepatocellular carcinoma cells, but not human hepatocytes, to TRAIL. Hepatology. 42:588–597. 2005. View Article : Google Scholar : PubMed/NCBI
13	Hall MA and Cleveland JL: Clearing the TRAIL for cancer therapy. Cancer Cell. 12:4–6. 2007. View Article : Google Scholar : PubMed/NCBI
14	Omar HA, Arafa el-SA, Maghrabi IA and Weng JR: Sensitization of hepatocellular carcinoma cells to Apo2L/TRAIL by a novel Akt/NF-κB signalling inhibitor. Basic Clin Pharmacol Toxicol. 114:464–471. 2014. View Article : Google Scholar : PubMed/NCBI
15	Refaat A, Abd-Rabou A and Reda A: TRAIL combinations: The new ‘trail’ for cancer therapy (Review). Oncol Lett. 7:1327–1332. 2014.PubMed/NCBI
16	Peinado H, Olmeda D and Cano A: Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
17	Pioli PD and Weis JH: Snail transcription factors in hematopoietic cell development: a model of functional redundancy. Exp Hematol. 42:425–430. 2014. View Article : Google Scholar : PubMed/NCBI
18	Kudo-Saito C, Shirako H, Takeuchi T and Kawakami Y: Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell. 15:195–206. 2009. View Article : Google Scholar : PubMed/NCBI
19	Miyoshi A, Kitajima Y, Kido S, Shimonishi T, Matsuyama S, Kitahara K and Miyazaki K: Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma. Br J Cancer. 92:252–258. 2005.PubMed/NCBI
20	Liu J, Jiang G, Liu S, Liu Z, Pan H, Yao R and Liang J: Lentivirus-delivered short hairpin RNA targeting SNAIL inhibits HepG2 cell growth. Oncol Rep. 30:1483–1487. 2013.PubMed/NCBI
21	Fellmann C and Lowe SW: Stable RNA interference rules for silencing. Nat Cell Biol. 16:10–18. 2014. View Article : Google Scholar :
22	Takakura Y: Towards therapeutic application of RNA-mediated gene regulation. Preface Adv Drug Deliv Rev. 61:6672009. View Article : Google Scholar
23	Djuranovic S, Nahvi A and Green R: A parsimonious model for gene regulation by miRNAs. Science. 331:550–553. 2011. View Article : Google Scholar : PubMed/NCBI
24	Jinek M and Doudna JA: A three-dimensional view of the molecular machinery of RNA interference. Nature. 457:405–412. 2009. View Article : Google Scholar : PubMed/NCBI
25	Liu X, Wang J, Wang H, Liu S, Liang Y, Lv Z, Zhou Q and Ding W: Combination of Ad-sTRAIL with the chemotherapeutic drug cisplatin synergistically enhances their pro-apoptotic ability in human breast cancer cells. Oncol Rep. 30:1913–1919. 2013.PubMed/NCBI
26	Chen D, Zheng X, Jiao X, Gao Y, Zhang K and Liang J: Transcriptional repressor snail and metastasis in hepatocellular carcinoma. Hepatogastroenterology. 59:1359–1365. 2012.
27	Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR and Yagita H: Nature’s TRAIL - on a path to cancer immunotherapy. Immunity. 18:1–6. 2003. View Article : Google Scholar : PubMed/NCBI
28	Abou El Naga RN, Azab SS, El-Demerdash E, Shaarawy S, El-Merzabani M and Ammar el-SM: Sensitization of TRAIL-induced apoptosis in human hepatocellular carcinoma HepG2 cells by phytochemicals. Life Sci. 92:555–561. 2013. View Article : Google Scholar : PubMed/NCBI
29	Liu X, Qiu F, Liu Z, Lan Y, Wang K, Zhou PK and Wang Y: Urokinase-type plasminogen activator receptor regulates apoptotic sensitivity of colon cancer HCT116 cell line to TRAIL via JNK-p53 pathway. Apoptosis. 19:1532–1544. 2014. View Article : Google Scholar : PubMed/NCBI
30	Zhao J, Lu Y and Shen HM: Targeting p53 as a therapeutic strategy in sensitizing TRAIL-induced apoptosis in cancer cells. Cancer Lett. 314:8–23. 2012. View Article : Google Scholar
31	Lee SH and Park BJ: p53 activation by blocking Snail: a novel pharmacological strategy for cancer. Curr Pharm Des. 17:610–617. 2011. View Article : Google Scholar : PubMed/NCBI
32	Finlay D, Vamos M, Gonzalez-Lopez M, et al: Small-molecule IAP antagonists sensitize cancer cells to TRAIL-induced apoptosis: roles of XIAP and cIAPs. Mol Cancer Ther. 13:5–15. 2014. View Article : Google Scholar :
33	Dougherty MK, Müller J, Ritt DA, Zhou M, Zhou XZ, Copelan TD, Conrads TP, Veenstra TD, Lu KP and Morrison DK: Regulation of Raf-1 by direct feedback phosphorylation. 17:215–224. 2005.
34	Akram KM, Lomas NJ, Forsyth NR and Spiteri MA: Alveolar epithelial cells in idiopathic pulmonary fibrosis display upregulation of TRAIL, DR4 and DR5 expression with simultaneous preferential over-expression of pro-apoptotic marker p53. Int J Clin Exp Pathol. 7:552–564. 2014.PubMed/NCBI
35	Yeh CH, Yang YY, Huang YF, Chow KC and Chen MF: Induction of apoptosis in human Hep3B hepatoma cells by norcantharidin through a p53 independent pathway via TRAIL/DR5 signal transduction. Chin J Integr Med. 18:676–682. 2012. View Article : Google Scholar : PubMed/NCBI
36	Inoue H, Shiraki K, Murata K, et al: Adenoviral-mediated transfer of p53 gene enhances TRAIL-induced apoptosis in human hepatocellular carcinoma cells. Int J Mol Med. 14:271–275. 2004.PubMed/NCBI
37	Cantarella G, Di Benedetto G, Ribatti D, Saccani-Jotti G and Bernardini R: Involvement of caspase 8 and c-FLIPL in the proangiogenic effects of the tumour necrosis factor-related apoptosis-inducing ligand (TRAIL). FEBS J. 281:1505–1513. 2014. View Article : Google Scholar : PubMed/NCBI
38	Guo XZ, Shao XD, Liu MP, Xu JH, Ren LN, Zhao JJ, Li HY and Wang D: Effect of bax, bcl-2 and bcl-xL on regulating apoptosis in tissues of normal liver and hepatocellular carcinoma. World J Gastroenterol. 8:1059–1062. 2002.PubMed/NCBI
39	Bansal H, Seifert T, Bachier C, Rao M, Tomlinson G, Iyer SP and Bansal S: The transcription factor Wilms tumor 1 confers resistance in myeloid leukemia cells against the proapoptotic therapeutic agent TRAIL (tumor necrosis factor alpha-related apoptosis-inducing ligand) by regulating the antiapoptotic protein Bcl-xL. J Biol Chem. 287:32875–32880. 2012. View Article : Google Scholar : PubMed/NCBI
40	Koehler BC, Urbanik T, Vick B, Boger RJ, Heeger S, Galle PR, Schuchmann M and Schulze-Bergkamen H: TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapies. World J Gastroenterol. 15:5924–5935. 2009. View Article : Google Scholar : PubMed/NCBI
41	Kaler P, Galea V, Augenlicht L and Klampfer L: Tumor associated macrophages protect colon cancer cells from TRAIL-induced apoptosis through IL-1beta-dependent stabilization of Snail in tumor cells. PLoS One. 5:e117002010. View Article : Google Scholar : PubMed/NCBI
42	Baritaki S and Bonavida B: Viral infection and cancer: the NF-kappaB/Snail/RKIP loop regulates target cell sensitivity to apoptosis by cytotoxic lymphocytes. Crit Rev Immunol. 30:31–46. 2010. View Article : Google Scholar : PubMed/NCBI
43	Wu K and Bonavida B: The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs. Crit Rev Immunol. 29:241–254. 2009. View Article : Google Scholar : PubMed/NCBI